Table 1.
Characteristics of 9 RCTs and 1 non-RCT, including Study ID, Year, Design, Sample size, Male/Female, Age, Etiological Factor
| Study ID(first author) | Year | Design | Sample size(participants) | Male/Female | Age | Etiological Factor |
|---|---|---|---|---|---|---|
| Osman Çekiç [12] | 2010 | RCT | 52 | 29/23 | 66.5 ± 0.3; 60.1 ± 3.9; 62.4 ± 1.5 | BRVO |
| Alex S. Willoughby [13] | 2018 | RCT | 38 | 20/18 | 66(range 37-) | RVO |
| J Moon [14] | 2016 | RCT | 41 | 22/19 | 60.57 ± 10.68; 58.83 ± 15.66 | BRVO |
| Chuanfeng Fan [15] | 2014 | 2014 | 57 | 28/29 | range 40–73 | CRVO |
| Peter A. Campochiaro [16] | 2017 | RCT | 46 | 23/23 | 68(range 37–91) | BRVO(19)/HRVO(1)/CRVO(26) |
| Kyungmin Lee [17] | 2013 | non-RCT | 151 | 16/15(IVTA); 51/44(IVB); 14/11(IVTA + IVB) | 57 ± 10(IVTA);58 ± 11(IVB);58 ± 11(IVTA + IVB) | BRVO |
| Raj K Maturi [18] | 2014 | RCT | 30 | 10/5(IVB);8/7(IVB + DEX) | 67 ± 13(IVB): 69 ± 19(IVB + DEX) | CRVO(15)/BRVO(15) |
| ZHAO Xue-zhang [20] | 2022 | RCT | 40 | 17/23 |
55.35 ± 10.24(IVTA); 56.24 ± 10.03(IVTA + IVC) |
CRVO |
| DUAN Yu-ping [21] | 2019 | RCT | 300 | 83/67 |
57.6 ± 5.4(IVTA); 57.5 ± 5.3(IVTA + IVC) |
RVO |
| Zheng Tan [19] | 2022 | RCT | 66 | 35/31 |
59.85 ± 8.20(IVA); 60.45 ± 8.00(IVA + IVTA) |
CRVO |